ArticleCancer science2010

Low-dose mithramycin exerts its anticancer effect via the p53 signaling pathway and synergizes with nutlin-3 in gynecologic cancers.

Tatsuhiro Ohgami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.